Portfolio company
GID
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops tissue processing platforms and cellular therapies that use a patient's own adipose cells to treat osteoarthritis and musculoskeletal conditions for physicians.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
SI-BONE
This company develops and sells implants and surgical systems for the treatment of musculoskeletal disorders in the sacropelvic anatomy for surgeons and hospitals.
AdipoSeeds
This biotech company develops adipose-derived mesenchymal stem cell platelets for regenerative medicine treatments and blood transfusion substitutes to assist healthcare providers and patients.
Gentis
This company developed an injectable biomaterial implant to restore biomechanical function in degenerated spinal discs for patients with spinal disc disease.
ALLEGRO
This company develops nanotechnology-based injectable hydrogel devices to treat osteoarthritis in human and veterinary patients.
Ossium Health
This company develops bone marrow-derived cell therapies and bone allografts for healthcare providers, life science companies and researchers treating blood and immune diseases.
Hyalex Orthopaedics
This company develops synthetic cartilage and implant systems to restore damaged joint surfaces for patients with osteoarthritis or cartilage injuries.
Atro Medical
This company develops synthetic meniscus prostheses to restore knee function and relieve pain for patients with chronic knee injuries.
EpiBone
This company grows personalized bone and cartilage grafts from a patient's own stem cells to treat individuals with skeletal defects.
